Detalles de la búsqueda
1.
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial.
BMC Infect Dis
; 24(1): 89, 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38225598
2.
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV).
J Infect Dis
; 228(10): 1318-1325, 2023 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470445
3.
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings.
Clin Infect Dis
; 75(1): e368-e379, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35323932
4.
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
Lancet Infect Dis
; 24(1): 36-45, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778363
5.
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).
Elife
; 122023 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36803992
Resultados
1 -
5
de 5
1
Próxima >
>>